CompletedNot Applicable

Colorectal Cancer Survivor Symptom Management

Turkey (Türkiye)40 participantsStarted 2023-07-11

Plain-language summary

Objective: The aim of this study was to examine the effects of nursing interventions based on the symptom management model on symptom management, fear of recurrence, and quality of life in colorectal cancer survivors. Method: The research was planned as a randomized controlled trial. The research is planned to be carried out at Akdeniz University Hospital. It is planned to be done with 52 patients, 26 experimental and 26 control groups. The intervention group will receive face-to-face training and telephone counseling based on the symptom management model. After the training, it is planned to provide telephone counseling for a total of 6 times, once every 2 weeks for 3 months. Participant Information Form, Memorial Symptom Assessment Scale, Fear of Cancer Recurrence Inventory and European Organization for the Research and Treatment of Cancer Quality of Life Questionnaire Scale Scale will be used to collect data.

Who can participate

Age range

18 Years

Sex

ALL

See this in plain English?

AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.

Inclusion criteria

. Be 18 years or older
. Being able to read and write
. Being oriented to place, time, person
. Not having a hearing problem
. Not having a speech problem
. Being able to use the phone
. Primary medical diagnosis is colorectal cancer
. Patients who have completed primary treatment for colorectal cancer and are followed up

Exclusion criteria

Questions worth asking your doctor

Bring these to your next appointment. They're a starting point for a shared conversation — not a sign you qualify or a recommendation to enrol.

1Based on my diagnosis and history, is this trial worth exploring for me — or is there a standard treatment we should try first?
2What does this trial's phase tell us about how much is already known about its safety and benefit?
3What would taking part actually involve for me — visits, tests, time, and travel?
4What are the known and possible risks or side effects I should weigh, and how would they be monitored?
5If this trial isn't the right fit, what other options or trials would you suggest I look into?

Generated to help you prepare — always confirm anything about your own eligibility and care with the study team and your doctor.

Questions for the trial coordinator

The trial coordinator is the person who runs the study day to day. These cover the practical side — logistics, costs, and what taking part would actually mean for your life. The study team confirms whether you meet the criteria; these are questions to ask, not a sign you qualify.

1What does taking part actually involve week to week — how many visits, where, and how long does each one take?
2What costs are covered by the study, and what might I have to pay for myself, including travel, parking, or time off work?
3What happens during screening, and what happens if the study team confirms I don't meet the criteria after those tests?
4Who pays for the scans, blood work, and other tests the trial requires — the study, my insurance, or me?
5How will being in the trial affect my regular care, and will my own doctor stay informed and involved?
6Can I leave the trial at any point if I change my mind, and what would happen to my care if I do?

A starting point for the conversation — always confirm anything about your own eligibility, costs, and care with the study team and your doctor.

What they're measuring

Change from Baseline in symptom management at week 12

Timeframe: Baseline, 4th week, 8th week and 12th week

Change from Baseline in Fear of Cancer Recurrence at week 12

Timeframe: Baseline and 12th week

Change from Baseline in Quality of Life Level on the EORTC QLQ-C30 Quality of Life Scale at week 12

Timeframe: Baseline and 12th week

Change from Baseline in Quality of Life Level on the EORTC QLQ-CR29 Quality of Life

Timeframe: Baseline and 12th week

Trial details

NCT IDNCT05876338

SponsorAkdeniz University

Sponsor typeOTHER

Study typeINTERVENTIONAL

Primary completion2024-06-05

View on ClinicalTrials.gov More Colorectal Cancer trials

Plain-language summary

Who can participate

Age range

18 Years

Sex

ALL

See this in plain English?

AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.

Inclusion criteria

. Be 18 years or older
. Being able to read and write
. Being oriented to place, time, person
. Not having a hearing problem
. Not having a speech problem
. Being able to use the phone
. Primary medical diagnosis is colorectal cancer
. Patients who have completed primary treatment for colorectal cancer and are followed up

Exclusion criteria

What they're measuring

Change from Baseline in symptom management at week 12

Timeframe: Baseline, 4th week, 8th week and 12th week

Change from Baseline in Fear of Cancer Recurrence at week 12

Timeframe: Baseline and 12th week

Change from Baseline in Quality of Life Level on the EORTC QLQ-C30 Quality of Life Scale at week 12

Timeframe: Baseline and 12th week

Change from Baseline in Quality of Life Level on the EORTC QLQ-CR29 Quality of Life

Timeframe: Baseline and 12th week